Cargando…
Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice
While most vaccines aim to develop a solid humoral and neutralizing antibody response against the pathogen, an effective vaccine candidate should be able to stimulate both the B-cell mediated humoral immunity, and T-cell mediated cellular immunity. The focus of vaccinology is rapidly gaining to gene...
Autores principales: | Aggarwal, Charu, Ramasamy, Viswanathan, Garg, Amit, Shukla, Rahul, Khanna, Navin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011089/ https://www.ncbi.nlm.nih.gov/pubmed/36926350 http://dx.doi.org/10.3389/fimmu.2023.1128784 |
Ejemplares similares
-
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
por: Shukla, Rahul, et al.
Publicado: (2020) -
Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach
por: Basheer, Amina, et al.
Publicado: (2023) -
Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022) -
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
por: Shukla, Rahul, et al.
Publicado: (2020) -
Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice
por: Rajpoot, Ravi Kant, et al.
Publicado: (2018)